Researchers at ICMR-National Institute for Research on Women's Health (NIRWoH, formerly NIRRCH), Mumbai, and IIT Bombay have developed an indigenous placenta-on-chip. It is a microfluidic device that recreates key placental functions; the work was reported on 4 July 2026.
The chip reproduces hormone production, glucose transfer, urea removal and the placenta's selective barrier. It also responds to high-glucose conditions resembling gestational diabetes.
It can be used to study pre-eclampsia, gestational diabetes and foetal growth restriction, and to test how drugs cross the placenta with less reliance on animal models.
The findings were published in the journal Biofabrication. The team includes Dr Deepak Modi (ICMR-NIRWoH) and Prof. Abhijit Majumder (IIT Bombay).
A small device with micro-channels lined with living human cells, with fluid flow that mimics blood. It reproduces how an organ behaves, so drug effects and diseases can be studied on human tissue in the lab instead of in animals.
Simple Analogy: A working miniature of an organ, the size of a USB stick.
Amended the NDCT Rules, 2019 to allow non-animal, human-relevant methods such as organoids, organ-on-chip and computational models in drug testing
ICMR institute for reproductive and women's health research; formerly NIRRCH
Apex body for biomedical research; under the Department of Health Research, Ministry of Health and Family Welfare
GS Paper III > Biotechnology; Indigenisation of Technology
General Science > Human Biology
Controlling tiny volumes of fluid in micro-channels
Pregnancy disorder marked by high blood pressure and organ damage
Diabetes first detected during pregnancy